Search results for "Liver"

showing 10 items of 4961 documents

Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal?

2015

Ultrasound-guided techniques play a key role in the clinical management of hepatocellular carcinoma. Among these, percutaneous ethanol injection (PEI) was the first technique to be proposed for the treatment of nodular-type hepatocellular carcinoma: the role of PEI was first discussed during the European Association for the Study of the Liver conference held in Barcelona in 2000, 15 years ago. Since then, other techniques have been introduced and radiofrequency ablation now represents the most widely used percutaneous technique. PEI and radiofrequency ablation are widely used in clinical practice. However, only scant progresses in the application of these techniques have been performed over…

medicine.medical_specialtyPercutaneousCarcinoma HepatocellularEthanolbusiness.industryRadiofrequency ablationmedicine.medical_treatmentLiver Neoplasmstechnology industry and agriculturemedicine.diseaseAblationUltrasound guidedSurgerylaw.inventionClinical PracticeOncologylawHepatocellular carcinomaCatheter AblationMedicineHumansPharmacology (medical)Percutaneous ethanol injectionbusinessUltrasonography InterventionalExpert review of anticancer therapy
researchProduct

Needle track seeding following percutaneous procedures for hepatocellular carcinoma.

2009

Neoplastic seeding may arise after diagnostic or therapeutic percutaneous procedures for hepatocellular carcinoma. The true incidence of seeding with hepatocellular carcinoma is difficult to assess precisely, but a significant risk of seeding exists and is greater when performing diagnostic biopsy as compared to therapeutic percutaneous procedures [radiofrequency ablation, radiofrequency ablation (RFA); percutaneous ethanol injection, Percutaneous ethanol injection (PEI)]. Whenever liver transplantation is feasible, diagnostic needle biopsies should be avoided, but RFA and PEI are often needed as “bridge” treatments. The role of adjuvant treatments in reducing the incidence of seeding follo…

medicine.medical_specialtyPercutaneousHepatologymedicine.diagnostic_testbusiness.industryRadiofrequency ablationmedicine.medical_treatmentReviewLiver transplantationmedicine.diseaselaw.inventionSurgerysurgical procedures operativelawLiver biopsyHepatocellular carcinomaBiopsymedicineSeedingPercutaneous ethanol injectionbusinessWorld journal of hepatology
researchProduct

Influence of Lymphangio (L), Vascular (V), and Perineural (Pn) Invasion on Recurrence and Survival of Resected Intrahepatic Cholangiocarcinoma

2021

(1) Background: Intrahepatic cholangiocarcinoma (ICC) is a rare malignancy. Besides tumor, nodal, and metastatic status, the UICC TNM classification describes further parameters such as lymphangio- (L0/L1), vascular (V0/V1/V2), and perineural invasion (Pn0/Pn1). The aim of this study was to analyze the influence of these parameters on recurrence and survival. (2) Methods: All surgical explorations for patients with ICC between January 2008 and June 2018 were collected and further analyzed in our institutional database. Statistical analyses focused on perineural, lymphangio-, and vascular invasion examined histologically and their influence on tumor recurrence and survival. (3) Results: Of 2…

medicine.medical_specialtyPerineural invasionMalignancyGastroenterologysurvivalArticleResectionVascular invasion03 medical and health sciences0302 clinical medicineintrahepatic cholangiocarcinomaInternal medicineStatistical analysesmedicineOverall survivalvascular invasionliver surgeryIntrahepatic Cholangiocarcinomabusiness.industryRlymphangioinvasionGeneral Medicineperineural invasionmedicine.diseaseTumor recurrence030220 oncology & carcinogenesisMedicine030211 gastroenterology & hepatologybusinessJournal of Clinical Medicine
researchProduct

Investigations of gestation-induced metabolic changes in the rat liver. I. Glycogen metabolism.

1979

The activities of alpha-glucan-phosphorylase and phosphoglucomutase and the concentration of glycogen were measured in the liver of pregnant and non-pregnant rats. There were no significant differences between normal non-pregnant and pregnant animals nor was there any change of enzyme activities during pregnancy. Our results lend support to the idea that glycogen metabolism is not changed during normal pregnancy.

medicine.medical_specialtyPhosphorylasesNormal pregnancychemistry.chemical_compoundPregnancyInternal medicinemedicineAnimalsskin and connective tissue diseasesreproductive and urinary physiologychemistry.chemical_classificationPregnancyGlycogenbusiness.industryGlycogen metabolismObstetrics and GynecologyGeneral Medicinemedicine.diseaseRatsEndocrinologyEnzymechemistryLiverPhosphoglucomutaseRat liverGestationPhosphoglucomutaseFemalesense organsbusinessGlycogenMathematicsArchives of gynecology
researchProduct

Expression of R-3-hydroxybutyrate dehydrogenase, a ketone body converting enzyme in heart and liver mitochondria of ruminant and non-ruminant mammals

1992

1. The properties of rat liver and bovine heart R-3-hydroxybutyrate dehydrogenase (BDH) have been extensively studied in the past 20 years, but little is known concerning the biogenesis and the regulation of this dehydrogenase over different species. 2. In addition, controversial results were often reported concerning the activity, the level and the subcellular location of this enzyme in ruminants. 3. BDH activity found in liver and kidney mitochondria from ruminants (cow and sheep) is low, while it is much higher in rat. 4. However, the enzyme activity is detected in microsomes and in cytosol of liver and of kidney cells from ruminants. These activities are not correlated to ketonaemia lev…

medicine.medical_specialtyPhysiologyBlotting WesternMitochondria LiverDehydrogenaseCross ReactionsBiologyMitochondrionKidneyBiochemistryMitochondria HeartHydroxybutyrate DehydrogenaseInternal medicinemedicineAnimalsHumansMolecular Biologychemistry.chemical_classificationKidneySheepGeneral MedicineEnzyme assayRatsCytosolEnzymemedicine.anatomical_structureEndocrinologyLiverchemistryBiochemistryMicrosomeKetone bodiesbiology.proteinCattleComparative Biochemistry and Physiology Part B: Comparative Biochemistry
researchProduct

Substance P inactivation by transglutaminase in vitro.

1992

Gamma(glutamyl5)spermine derivative of substance P (Spm-SP) was synthesized in vitro in the presence of purified guinea pig liver transglutaminase and Ca2+. The spermine adduct of the neuropeptide was purified by HPLC on a reversed-phase column and characterized by fast atom bombardment mass spectrometry. The biological activities of Spm-SP were tested by assaying, in comparison with substance P, its ability to induce both the contractions of smooth muscle in vitro and the edema formation in vivo. Spm-SP was shown not to elicit contractile responses in the isolated rat stomach strip and duodenum and not to antagonize the spasmogenic effect evoked by the native neuropeptide. Furthermore, Spm…

medicine.medical_specialtyPhysiologyGuinea PigsMolecular Sequence DataHistamine AntagonistsNeuropeptideSpermineSubstance PSubstance PPharmacologyBiochemistryCellular and Molecular Neurosciencechemistry.chemical_compoundEndocrinologyIn vivoInternal medicinemedicineAnimalsEdemaAmino Acid SequenceReceptorPeptide modificationTransglutaminasesChemistryExtremitiesMuscle SmoothBiological activityIn vitroEndocrinologyLiverHistamineMuscle Contraction
researchProduct

Early, but not late onset estrogen replacement therapy prevents oxidative stress and metabolic alterations caused by ovariectomy.

2014

Aims: The usefulness of estrogen replacement therapy (ERT) in preventing oxidative stress associated with menopause is controversial. We aimed to study if there is a critical time window for effective treatment of the effects of ovariectomy with estrogens at the molecular, metabolic, and cellular level. Results: Our main finding is that early, but not late onset of ERT prevents an ovariectomy-associated increase in mitochondrial hydrogen peroxide levels, oxidative damage to lipids and proteins, and a decrease in glutathione peroxidase and catalase activity in rats. This may be due to a change in the estrogen receptor (ER) expression profile: ovariectomy increases the ER α/β ratio and immedi…

medicine.medical_specialtyPhysiologymedicine.drug_classGlucose uptakeOvariectomyClinical BiochemistryGlucose Transport Proteins FacilitativeEstrogen receptorMitochondria LiverBiologymedicine.disease_causeBiochemistryAntioxidantsInternal medicinemedicineAnimalsMetabolomicsMolecular BiologyGeneral Environmental Sciencechemistry.chemical_classificationEstradiolGlutathione peroxidaseEstrogen Replacement TherapyGlucose transporterBrainCell BiologyHydrogen Peroxidemedicine.diseaseRatsMenopauseOxidative StressOriginal Research CommunicationsEndocrinologyGlucosechemistryEstrogenCatalasebiology.proteinGeneral Earth and Planetary SciencesFemaleOxidative stressAntioxidantsredox signaling
researchProduct

Implication of Normal Liver Enzymes in Liver Disease

2009

Summary.  Chronic liver disease is usually asymptomatic until its late stages and also significant hepatic necroinflammation and fibrosis may be present in persistently normal ALT levels HBV, HCV carriers or similarly, in patients with nonalcoholic fatty liver disease. Given the large number of persons in the general population which may harbor a clinically significant liver disease behind the screen of normal alanine aminotransferase, more attention should be devoted to future research for alternative noninvasive markers of liver damage.

medicine.medical_specialtyPopulationChronic liver diseaseaminotransferases chronic hepatitis liver fibrosisGastroenterologySensitivity and SpecificityLiver diseaseVirologyInternal medicineNonalcoholic fatty liver diseasemedicineHumanseducationeducation.field_of_studyHepatologymedicine.diagnostic_testbusiness.industryLiver DiseasesFatty liverAlanine TransaminaseHepatitis Cmedicine.diseaseInfectious DiseasesLiverHepatic fibrosisLiver function testsbusiness
researchProduct

Primary Biliary Cholangitis management: controversies, perspectives, and daily practice implications from an expert panel

2020

Primary biliary cholangitis (PBC) is a rare progressive immune-mediated liver disease that, if not adequately treated, may culminate in end-stage disease and need for transplantation. According to current guidelines, PBC is diagnosed in the presence of antimitochondrial antibodies (AMA) or specific antinuclear antibodies, and of a cholestatic biochemical profile, while biopsy is recommended only in selected cases. All patients receive ursodeoxycholic acid (UDCA) in first line; the only registered second-line therapy is obeticholic acid (OCA) for UDCA-inadequate responders. Despite the recent advances in understanding PBC pathogenesis and developing new treatments, many grey areas remain. Si…

medicine.medical_specialtyPopulationReceptors Cytoplasmic and NuclearDiseaserisk stratificationfibrates; liver biopsy; management; obeticholic acid; primary biliary cholangitis; risk stratificationprimary biliary cholangitiBile Acids and Salts03 medical and health scienceschemistry.chemical_compoundLiver disease0302 clinical medicineobeticholic acidBiopsymedicineHumansIntensive care medicineeducationliver biopsyeducation.field_of_studyCholestasisfibrateHepatologymedicine.diagnostic_testbusiness.industryprimary biliary cholangitisLiver Cirrhosis BiliaryUrsodeoxycholic AcidObeticholic acidmedicine.diseaseUrsodeoxycholic acidBile Acids and SaltTransplantationchemistryCholestasi030220 oncology & carcinogenesisLiver biopsy030211 gastroenterology & hepatologyfibratesbusinessmanagementmedicine.drugHuman
researchProduct

Hepatic mesenchymal hamartoma in a preterm newborn: demonstration by low-dose multidetector CT.

2007

Primary liver tumours are very rare in the neonatal period. Differential diagnoses include haemangioendothelioma, malignant hepatoblastoma and mesenchymal hamartoma. Due to non-specific clinical symptoms and indecisive imaging findings, correct diagnosis may be difficult to establish. We report a female preterm newborn who was delivered at 33 weeks of gestation and in whom ultrasonography (US) revealed a large cystic intraabdominal tumour of unknown origin. For further evaluation, contrast-enhanced multidetector computed tomography (CT) was performed on the 4th day of life using a low-dose protocol (80 kVp, 50 mAs, collimation 0.75 mm, total effective dose 3.6 mSv). Based on CT findings, di…

medicine.medical_specialtyPregnancyHepatoblastomabusiness.industryHamartomaLiver DiseasesMesenchymal stem cellLiver NeoplasmsInfant NewbornGeneral MedicineMultidetector ctmedicine.diseaseEffective dose (radiation)MesodermPediatrics Perinatology and Child HealthmedicineGestationHamartomaHumansFemaleRadiologyMedical diagnosisbusinessInfant PrematureTomography Emission-ComputedActa paediatrica (Oslo, Norway : 1992)
researchProduct